FMGE · blueprint and recall
FMGE Anticancer drugs
Candidates recalled anticancer drugs from 14 of the 19 FMGE sessions in this collection, including 10 of the 11 well-covered ones. It first appears in FMGE Jun 2009 and last in FMGE Jan 2026. 10 of its 13 recalled concepts came as one-liners.
- Concepts in recalled topics
- 13
- unofficial
- Sessions seen in
- 14
- Well-covered sessions
- 10
- with this topic recorded
- Image-linked concepts
- 0
Recurrence in this collection
Each recalled session counts once for this topic, even if it contains several related concepts.
Seen in 14 of the 19 sessions with recall; 10 of the 11 well-covered sessions.
First seen: FMGE Jun 2009. Last seen: FMGE Jan 2026.
First and last seen refer to this recall collection only. Thin coverage limits what absence can tell you. Read the method.
Question styles and image links
Question styles in the recall
- one-liner
- 10 concepts · 76.9%
- vignette
- 3 concepts · 23.1%
Within this topic
Finer labels from the unofficial recall, grouped under Lumi's outline topic.
Subtopics represented
- Bleomycin toxicity
- Haematopoietic growth factors
- Platinum compounds
- Methotrexate
- Targeted therapy
- Anticancer toxicity
Image types recorded
No concepts recorded in this category.
Image-type percentages use all 13 concepts in this topic as the denominator. The labels describe images in recall; no images are reproduced.
Related topics in this chapter
Chemotherapy
Antimalarials and anthelmintics
Seen in 6 of the 19 sessions with recall; 5 of the 11 well-covered sessions.
First seen: FMGE Jun 2009. Last seen: FMGE Jul 2025.
Styles: one-liner (4) · vignette (1).
Chemotherapy
Fluoroquinolones and others
Seen in 5 of the 19 sessions with recall; 4 of the 11 well-covered sessions.
First seen: FMGE Dec 2010. Last seen: FMGE Jul 2025.
Styles: one-liner (6) · vignette (1).
Chemotherapy
Antifungals
Seen in 4 of the 19 sessions with recall; 3 of the 11 well-covered sessions.
First seen: FMGE Jun 2011. Last seen: FMGE Jul 2025.
Styles: one-liner (1) · vignette (1).
Chemotherapy
Antivirals
Seen in 3 of the 19 sessions with recall; 3 of the 11 well-covered sessions.
First seen: FMGE Jun 2009. Last seen: FMGE Dec 2020.
Styles: one-liner (3) · image + vignette (1).
Chemotherapy
Aminoglycosides, macrolides and tetracyclines
Seen in 3 of the 19 sessions with recall; 2 of the 11 well-covered sessions.
First seen: FMGE Dec 2011. Last seen: FMGE Jan 2025.
Styles: one-liner (3).
Chemotherapy
Beta-lactams
Seen in 2 of the 19 sessions with recall; 2 of the 11 well-covered sessions.
First seen: FMGE Jun 2019. Last seen: FMGE Aug 2020.
Styles: one-liner (1) · vignette (1).
Chemotherapy
Antitubercular and antileprotic drugs
Seen in 1 of the 19 sessions with recall; 0 of the 11 well-covered sessions.
First seen: FMGE Dec 2010. Last seen: FMGE Dec 2010.
Styles: one-liner (1).